Intravenous lidocaine: it's all about a risk-benefit analysis
- PMID: 33591569
- DOI: 10.1111/anae.15436
Intravenous lidocaine: it's all about a risk-benefit analysis
Comment in
-
Intravenous lidocaine: benefits require better evidence, and potential risks apply to all team members.Anaesthesia. 2021 May;76(5):718-719. doi: 10.1111/anae.15439. Epub 2021 Feb 16. Anaesthesia. 2021. PMID: 33591568 No abstract available.
Comment on
-
Unlicensed intravenous lidocaine for postoperative pain: always a safer 'licence to stop' than to start.Anaesthesia. 2021 Feb;76(2):156-160. doi: 10.1111/anae.15286. Epub 2020 Nov 3. Anaesthesia. 2021. PMID: 33141932 No abstract available.
References
-
- Pandit JJ, McGuire N. Unlicensed intravenous lidocaine for postoperative pain: always a safer 'licence to stop' than to start. Anaesthesia 2021; 76: 156-60.
-
- Hollmann MW, Strumper D, Durieux ME. The poor man's epidural: systemic local anesthetics for improving postoperative outcomes. Medical Hypotheses 2004; 63: 386-9.
-
- Vigneault L, Turgeon AF, Cote D, et al. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Canadian Journal of Anesthesia 2011; 58: 22-37.
-
- Kranke P, Jokinen J, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database of Systematic Reviews 2015; 7: CD009642.
-
- Grassi P, Bregant GM, Crisman M. Systemic intravenous lidocaine for perioperative pain management: a call for changing indications in the package sheet. Heart, Lung and Vessels 2014; 6: 137-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources